Skip to content

ERNAW ERNEXA THERAPEUTICS INC

Follow

*W EXP 02/04/203 (warrant or right), issuer CIK 748592

Filings received so far for Q3 2026: 7 13F filers report a position in ERNAW shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Bleichroeder LPin group Bleichroeder LP2,000,000$63.4K0.01%013F-HRTimelineGroup
HEIGHTS CAPITAL MANAGEMENT, INCin group HEIGHTS CAPITAL MANAGEMENT, I…400,000$14K<0.01%013F-HRTimelineGroup
SUSQUEHANNA INTERNATIONAL GROUP, LLPin group SUSQUEHANNA INTERNATIONAL GRO…158,456$5.55K<0.01%+100,56613F-HRTimelineGroup
ARMISTICE CAPITAL, LLCin group ARMISTICE CAPITAL, LLC160,000$5.07K<0.01%013F-HRTimelineGroup
Clear Street Group Inc.in group Clear Street Group Inc.150,679$4.78K<0.01%+1,18013F-HRTimelineGroup
Warberg Asset Management LLC60,359$1.91K<0.01%-9,07113F-HRTimeline
HRT FINANCIAL LP22,346$00%new13F-HRTimelineValue filed as zero, left out of ratios.